MedTrace Logo

Sharing HaRT in New Expanses

NCT06237439 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 302

Last updated 2024-02-01

No results posted yet for this study

Summary

The goal of this parallel cluster randomized control (CRT) trial is to evaluate a group-based mind-body intervention (Move with HaRT) in survivors of human trafficking. The main study aims are:

1. Determine effectiveness of the Move with HaRT intervention on PTSD, depression, and anxiety symptoms among survivors of human trafficking in Uganda
2. Explore participant characteristics (e.g., age, trafficking history, food security) that may moderate the intervention effectiveness.
3. Understand potential barriers and facilitators to future implementation and scale-up.

Participants will complete:

* Complete three surveys (baseline, endline, and 3 month follow-up)
* Participate in either Services as Usual or Move with HaRT groups
* Qualitative in-depth interviews

Researchers will compare Move with HaRT with Services as Usual to see effects on mental health symptoms.

Conditions

  • Depressive Symptoms
  • Trauma, Psychological
  • Anxiety Generalized

Interventions

BEHAVIORAL

Move with HaRT

Move with HaRT is a group-based, manualized mind-body intervention.

Sponsors & Collaborators

  • Innovations for Poverty Action

    collaborator OTHER

  • University of Alabama, Tuscaloosa

    lead OTHER

Principal Investigators

  • Catherine E Carlson · University of Alabama at Birmingham

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-21
Primary Completion
2025-02-28
Completion
2025-05-31

Countries

  • Uganda

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06237439 on ClinicalTrials.gov